Literature DB >> 786679

Ketoprofen and indomethacin in the treatment of rheumatoid arthritis: a double-blind cross-over trial.

R Franchi, M Viara, C Liverta, C Pollini, A E Pontiroli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 786679     DOI： 10.1007/bf00567116

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS.

Authors:  J E GRIZZLE
Journal:  Biometrics       Date:  1965-06       Impact factor: 2.571

2.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

3.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

4.  Orudis in management of rheumatoid arthritis and osteoarthrosis of the hip: comparison with indomethacin.

Authors:  A N Gyory; M Bloch; H C Burry; R Grahame
Journal:  Br Med J       Date:  1972-11-18

5.  Further experience with indomethacin in the treatment of rheumatic disorders.

Authors:  M Thompson; J S Percy
Journal:  Br Med J       Date:  1966-01-08

6.  Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.

Authors:  B J Cathcart; J D Vince; A J Gordon; M A Bell; I M Chalmers
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103
  6 in total
  1 in total

1.  Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay.

Authors:  R A Upton; R L Williams; T W Guentert; J N Buskin; S Riegelman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.